Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: A study on the pharmacokinetic bioequivalence of oral tablet formulations of riluzole among healthy volunteers utilizing HPLC-MS/MS

Fig. 1

Mean plasma concentration-time curves of riluzole after administering a single 50-mg oral dose of both the test and reference formulations in fasting conditions. The upper right inset displays a time frame of 0–2 h on an enlarged scale. T, test formulation (produced by Jiangsu Nhwa Pharmaceutical Co., Ltd, China); R, reference formulation (produced by Sanofi Winthrop Industrie, France)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us